VRT-325 is a CFTR-f508delt corrector that modifies the channel function. Phe508 (f508del) deletion is the most common cystic fibrosis mutation.

815592-21-3

C27H34N4O4S

510.65

CFcor-325;CFcor325;VRT325;CFcor 325;VRT 325;VRT-325

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years